Thanks to research-driven advances in diagnosis, detection, and treatment, overall age-adjusted cancer death rates in the U.S. have decreased by 33 percent from 1991 to 2020, a reduction that translates into 3.8 million lives saved.
Learn MoreCancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreTargeting “Undruggable” Proteins That Drive Cancer: AACR grantee Raymond E. Moellering, PhD, uses chemistry to build “molecules that can go after undruggable protein targets” to treat cancers.
Read AACR StoriesNearly 153,000 people in the U.S. are expected to be diagnosed with colorectal cancer this year. Read about the prevention, screening, and treatment options for this type of cancer.
Learn MoreGet updates on research driven advances in cancer science and medicine including the recent AACR Annual Meeting 2024 in San Diego on the AACR Blog.
Read the AACR BlogThe current issue of Leading Discoveries magazine is available with articles on CAR T-cell pioneer Carl H. June, MD, FAACR, research updates from the AACR journals and scientific meetings, and more.
Read Leading DiscoveriesWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowSession recordings are available for viewing to registered attendees through July 10. Registration remains open for the on-demand virtual meeting.
The AACR Cancer Disparities Progress Report 2024 outlines the complex interplay of factors that drive and perpetuate cancer health disparities and calls for a collaborative approach to achieve health equity.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreDr. Winn, chair of the AACR Cancer Disparities Progress Report 2024 steering committee, discusses the many factors that drive and perpetuate cancer health disparities.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2020
Learn Moretherapeutics were approved for new or expanded uses by the FDA from Aug. 1, 2022, to July 31, 2023
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn More